Roes, J. and Rajewsky, K. (1993). Immunoglobulin D (IgD)-<strong>de</strong>ficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med 177, 45-55. Rogers, J., Choi, E., Souza, L., Carter, C., Word, C., Kuehl, M., Eisenberg, D. and Wall, R. (1981). Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. Cell 26, 19-27. Rogers, J., Early, P., Carter, C., Ca<strong>la</strong>me, K., Bond, M., Hood, L. and Wall, R. (1980). Two mRNAs with different 3' ends enco<strong>de</strong> membrane-bound and secreted forms of immunoglobulin mu chain. Cell 20, 303-12. Rogers, J. and Wall, R. (1984). Immunoglobulin RNA rearrangements in B lymphocyte differentiation. Adv Immunol 35, 39-59. Rolink, A. G., An<strong>de</strong>rsson, J. and Melchers, F. (2004). Molecu<strong>la</strong>r mechanisms guiding <strong>la</strong>te stages of B-cell <strong>de</strong>velopment. Immunol Rev 197, 41-50. Rooney, S., Sekiguchi, J., Whitlow, S., Eckersdorff, M., Manis, J. P., Lee, C., Ferguson, D. O. and Alt, F. W. (2004). Artemis and p53 cooperate to suppress oncogenic Nmyc amplification in progenitor B cells. Proc Natl Acad Sci U S A 101, 2410-5. Roseman, S. (1970). The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellu<strong>la</strong>r adhesion. Chem Phys Lipids 5, 270-97. Rossi, B., Espeli, M., Schiff, C. and Gauthier, L. (2006). Clustering of pre-B cell integrins induces galectin-1-<strong>de</strong>pen<strong>de</strong>nt pre-B cell receptor relocalization and activation. J Immunol 177, 796-803. Roth, D. B. and Roth, S. Y. (2000). Unequal access: regu<strong>la</strong>ting V(D)J recombination through chromatin remo<strong>de</strong>ling. Cell 103, 699-702. Roth, J. (2002). Protein N-glycosy<strong>la</strong>tion along the secretory pathway: re<strong>la</strong>tionship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 102, 285-303. Roth, J., Wang, Y., Eckhardt, A. E. and Hill, R. L. (1994). Subcellu<strong>la</strong>r localization of the UDP-N-acetyl-D-ga<strong>la</strong>ctosamine: polypepti<strong>de</strong> N-acetylga<strong>la</strong>ctosaminyltransferase-mediated Oglycosy<strong>la</strong>tion reaction in the submaxil<strong>la</strong>ry g<strong>la</strong>nd. Proc Natl Acad Sci U S A 91, 8935-9. Roth, P. E., Doglio, L., Manz, J. T., Kim, J. Y., Lo, D. and Storb, U. (1993). Immunoglobulin gamma 2b transgenes inhibit heavy chain gene rearrangement, but cannot promote B cell <strong>de</strong>velopment. J Exp Med 178, 2007-21. Roth, P. E., Kurtz, B., Lo, D. and Storb, U. (1995). <strong>la</strong>mbda 5, but not mu, is required for B cell maturation in a unique gamma 2b transgenic mouse line. J Exp Med 181, 1059-70. Saito, T., Chiba, S., Ichikawa, M., Kunisato, A., Asai, T., Shimizu, K., Yamaguchi, T., Yamamoto, G., Seo, S., Kumano, K. et al. (2003). Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage <strong>de</strong>velopment. Immunity 18, 675-85. Sakaguchi, N., Kashiwamura, S., Kimoto, M., Thalmann, P. and Melchers, F. (1988). B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. Embo J 7, 3457-64. Sakai, E., Bottaro, A. and Alt, F. W. (1999). The Ig heavy chain intronic enhancer core region is necessary and sufficient to promote efficient c<strong>la</strong>ss switch recombination. Int Immunol 11, 1709-13. Salmivirta, M., Lidholt, K. and Lindahl, U. (1996). Heparan sulfate: a piece of information. Faseb J 10, 1270-9. Sasaki, Y., Caso<strong>la</strong>, S., Kutok, J. L., Rajewsky, K. and Schmidt-Supprian, M. (2004). TNF family member B cell-activating factor (BAFF) receptor-<strong>de</strong>pen<strong>de</strong>nt and -in<strong>de</strong>pen<strong>de</strong>nt roles for BAFF in B cell physiology. J Immunol 173, 2245-52. 172
Sato, M., Adachi, T. and Tsubata, T. (2007). Augmentation of signaling through BCR containing IgE but not that containing IgA due to <strong>la</strong>ck of CD22-mediated signal regu<strong>la</strong>tion. J Immunol 178, 2901-7. Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N. and Raju, T. S. (2007). Higher levels of sialy<strong>la</strong>ted Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44, 1524-34. Schamel, W. W. and Reth, M. (2000a). Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13, 5-14. Schamel, W. W. and Reth, M. (2000b). Stability of the B cell antigen receptor complex. Mol Immunol 37, 253-9. Schatz, D. G., Oettinger, M. A. and Baltimore, D. (1989). The V(D)J recombination activating gene, RAG-1. Cell 59, 1035-48. Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E. and Scott, M. L. (2001). An essential role for BAFF in the normal <strong>de</strong>velopment of B cells through a BCMA-in<strong>de</strong>pen<strong>de</strong>nt pathway. Science 293, 2111-4. Schilham, M. W., Wilson, A., Moerer, P., Benaissa-Trouw, B. J., Cumano, A. and Clevers, H. C. (1998). Critical involvement of Tcf-1 in expansion of thymocytes. J Immunol 161, 3984-91. Schlissel, M. S. (2003). Regu<strong>la</strong>ting antigen-receptor gene assembly. Nat Rev Immunol 3, 890-9. Schonherr, E., Witsch-Prehm, P., Harrach, B., Robenek, H., Rauterberg, J. and Kresse, H. (1995). Interaction of biglycan with type I col<strong>la</strong>gen. J Biol Chem 270, 2776-83. Schra<strong>de</strong>r, C. E., Linehan, E. K., Mochegova, S. N., Wood<strong>la</strong>nd, R. T. and Stavnezer, J. (2005). Inducible DNA breaks in Ig S regions are <strong>de</strong>pen<strong>de</strong>nt on AID and UNG. J Exp Med 202, 561-8. Schubart, K., Massa, S., Schubart, D., Corcoran, L. M., Rolink, A. G. and Matthias, P. (2001). B cell <strong>de</strong>velopment and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nat Immunol 2, 69-74. Schwartz, N. B. and Domowicz, M. (2002). Chondrodysp<strong>la</strong>sias due to proteoglycan <strong>de</strong>fects. Glycobiology 12, 57R-68R. Schweighoffer, E., Vanes, L., Mathiot, A., Nakamura, T. and Tybulewicz, V. L. (2003). Unexpected requirement for ZAP-70 in pre-B cell <strong>de</strong>velopment and allelic exclusion. Immunity 18, 523-33. Sekiguchi, J. M. and Ferguson, D. O. (2006). DNA double-strand break repair: a relentless hunt uncovers new prey. Cell 124, 260-2. Sen, R. (2005). A move to exclu<strong>de</strong>. Nat Immunol 6, 128-30. Serwe, M. and Sablitzky, F. (1993). V(D)J recombination in B cells is impaired but not blocked by targeted <strong>de</strong>letion of the immunoglobulin heavy chain intron enhancer. Embo J 12, 2321-7. Shaffer, A. L., Lin, K. I., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Ca<strong>la</strong>me, K. et al. (2002). Blimp-1 orchestrates p<strong>la</strong>sma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17, 51-62. Shaffer, A. L. and Schlissel, M. S. (1997). A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell <strong>de</strong>velopment. J Immunol 159, 1265-75. Shafi, R., Iyer, S. P., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W. and Marth, J. D. (2000). The O-GlcNAc transferase gene resi<strong>de</strong>s on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 97, 5735-9. 173
- Page 1:
UNIVERSITE DE LIMOGES Ecole doctora
- Page 4 and 5:
de m’avoir donnée le goût pour
- Page 6 and 7:
KO : « knock-out » : délétion d
- Page 8 and 9:
Figure 27 : Les trois types de N-gl
- Page 10 and 11:
5.2.2. Les galectines, les voies No
- Page 13 and 14:
Afin d’assurer la défense de l
- Page 15:
conduire les cellules B au long de
- Page 19 and 20:
Les immunoglobulines sont des hét
- Page 21 and 22:
antigènes et dans la transduction
- Page 23 and 24:
1.2.2 Le Locus Igλ Les gènes de c
- Page 25 and 26:
empêcher des recombinaisons illég
- Page 27 and 28:
de l’ADN est réalisée par les p
- Page 29 and 30:
Figure 8 : Les nucléotides N et P.
- Page 31 and 32:
séquences Ig (Goodhardt et al., 19
- Page 33 and 34:
B, le nombre de cellules exprimant
- Page 35 and 36:
Des promoteurs ont également été
- Page 37 and 38:
maturation : aux stades précoces,
- Page 39 and 40:
jusqu’à Cδ, ne supprime pas pou
- Page 41 and 42:
3.1 La phase indépendante des anti
- Page 43 and 44:
Novobrantseva et al., 1999) et que
- Page 45 and 46:
Figure 14 : Bilan des blocages part
- Page 47 and 48:
Dendritic Cells »). Elles devienne
- Page 49 and 50:
sécrétrices est controversée. De
- Page 51 and 52:
et al., 2000; Chumley et al., 2000;
- Page 53 and 54:
La commutation isotypique, permetta
- Page 55 and 56:
L’action des cytokines semble s
- Page 57 and 58:
l’hypermutation (Muramatsu et al.
- Page 59 and 60:
IV. L’activation des lymphocytes
- Page 61 and 62:
La translocation du BCR après pont
- Page 63 and 64:
protéines. La protéine ZAP-70 ét
- Page 65 and 66:
comme NF-κB (Krappmann et al., 200
- Page 67 and 68:
démontré que CD22 était continue
- Page 69 and 70:
Figure 24 : Comparaison des région
- Page 71 and 72:
Au cours du développement B, le pr
- Page 73 and 74:
membranaire s’avère possible exp
- Page 75 and 76:
IgM/IgD (Brink et al., 1992; Spanop
- Page 77 and 78:
V. « Glycannes et glycoconjugués
- Page 79 and 80:
Groupe d'enzymes Sialyltransférase
- Page 81 and 82:
L’édification d’une structure
- Page 83 and 84:
5.1.2. La O-glycosylation des prot
- Page 85 and 86:
• la O-glucosylation qui a lieu s
- Page 87 and 88:
Les protéoglycannes peuvent varier
- Page 89 and 90:
o L’Héparane Sulfate (HS) et l
- Page 91 and 92:
C’est le premier hexosamine greff
- Page 93 and 94:
égion constante. L’analyse des d
- Page 95 and 96:
pathologies pour lesquelles l’ars
- Page 97 and 98:
intégrines VLA-4, VLA-5 et α4β7,
- Page 99 and 100:
thymocytes double négatifs CD4- CD
- Page 101 and 102:
délétion conditionnelle des gène
- Page 103 and 104:
Dans la MEC, les protéoglycannes f
- Page 105 and 106:
endothéliale, de façon à permett
- Page 107 and 108:
Résultats - Discussion 107
- Page 109 and 110:
Première partie : les BCR modifié
- Page 111 and 112:
Article 1 “Premature expression o
- Page 113 and 114:
Article 2 “B cells carying an IgE
- Page 115 and 116:
Demande de dépôt de brevet Etabli
- Page 117 and 118:
mécanismes relèvent les différen
- Page 119 and 120:
Etablissement et caractérisation d
- Page 121 and 122: AUSUBEL, 2000, Wiley and son Inc, L
- Page 123 and 124: 4) Dosage du taux des IgG1 sérique
- Page 125 and 126: - distribution d’un antisérum an
- Page 127 and 128: périphériques expriment pour envi
- Page 129 and 130: C. CONCLUSION Ce travail a reposé
- Page 131 and 132: Deuxième partie : les glycosaminog
- Page 133 and 134: Article 3 “Modulation of glycotra
- Page 135 and 136: Perspectives 135
- Page 137 and 138: L’état des réflexions sur les i
- Page 139 and 140: équipes de Tsubata et Goodnow avai
- Page 141 and 142: L’ouverture d’un nouveau champ
- Page 143 and 144: « Lymphomagenèse » dirigé par l
- Page 145 and 146: Annexes 145
- Page 147 and 148: Article 4 “RNA surveillance down-
- Page 149 and 150: Article 5 “Light chain inclusion
- Page 151 and 152: Références Bibliographiques 151
- Page 153 and 154: Abney, E. R., Cooper, M. D., Kearne
- Page 155 and 156: Brink, R., Goodnow, C. C., Crosbie,
- Page 157 and 158: Cogne, M., Lansford, R., Bottaro, A
- Page 159 and 160: Franke, T. F., Kaplan, D. R., Cantl
- Page 161 and 162: Hauke, G., Epplen, J. T., Chluba, J
- Page 163 and 164: Kao, Y. H., Lee, G. F., Wang, Y., S
- Page 165 and 166: Lieberson, R., Giannini, S. L., Bir
- Page 167 and 168: Meek, K. D., Hasemann, C. A. and Ca
- Page 169 and 170: Oberdoerffer, P., Novobrantseva, T.
- Page 171: Poellinger, L., Yoza, B. K. and Roe
- Page 175 and 176: Functional immunoglobulin transgene
- Page 177 and 178: Vilen, B. J., Famiglietti, S. J., C
- Page 179 and 180: Zarrin, A. A., Tian, M., Wang, J.,